Who this is for: CDL drivers, fleet managers, owner-operators, compliance assistants
DOT Drug and Alcohol Testing for CDL Drivers — Overview
All CDL drivers operating commercial motor vehicles in interstate commerce are subject to DOT drug and alcohol testing under 49 CFR Part 382. Testing covers five drug categories and alcohol. Required test types include pre-employment, random, post-accident, reasonable suspicion, and return-to-duty.
Important Notice
This page is an educational overview. Federal drug and alcohol testing rules are set in 49 CFR Parts 382 and 40. Consult the official regulations or a qualified compliance professional for program setup and driver-specific questions.
Who is covered by DOT drug and alcohol testing
DOT drug and alcohol testing under 49 CFR Part 382 applies to any driver who operates a commercial motor vehicle (CMV) requiring a CDL in interstate commerce. This includes full-time, part-time, casual, and intermittent drivers. Owner-operators with their own DOT authority are covered. Drivers who operate intrastate may be subject to state-level rules — check your state DOT.
What drugs are tested (the five-panel DOT drug test)
The DOT-mandated urine drug test screens for five categories of controlled substances: (1) marijuana (THC metabolites); (2) cocaine metabolites; (3) opioids — including codeine, morphine, heroin (6-AM), hydrocodone, hydromorphone, oxycodone, and oxymorphone; (4) phencyclidine (PCP); and (5) amphetamines — including methamphetamine, MDMA, and MDA. A verified positive result for any substance triggers a Clearinghouse violation and disqualifies the driver from safety-sensitive functions.
Alcohol testing thresholds
Alcohol breath testing is conducted under 49 CFR Part 40 procedures. A result of 0.04 BAC or higher while on duty constitutes a DOT alcohol violation and prohibits the driver from safety-sensitive functions. A result between 0.02 and 0.039 BAC requires removal from duty for 24 hours but is not reported as a violation (no Clearinghouse entry). A result below 0.02 is negative. Alcohol testing measures current impairment — unlike drug testing, there is no metabolite lag.
When DOT testing is required
There are six circumstances that require DOT drug and/or alcohol testing: (1) Pre-employment — before a driver begins safety-sensitive functions for a new employer; (2) Random — unannounced, at federally mandated annual rates; (3) Post-accident — after certain CMV accidents meeting defined thresholds; (4) Reasonable suspicion — when a trained supervisor observes specific behavioral signs; (5) Return-to-duty — before a driver with a violation resumes safety-sensitive functions; and (6) Follow-up — after return to duty, per a Substance Abuse Professional's plan.
How the testing process works
DOT drug testing uses a split-specimen urine collection following strict chain-of-custody procedures under 49 CFR Part 40. A trained collector collects the specimen at a certified collection site. The primary specimen is sent to a SAMHSA-certified laboratory. Results are reviewed by a Medical Review Officer (MRO) before being reported to the employer. If the driver disputes a positive result, the second (B) specimen can be sent to another certified lab.
Role of the Medical Review Officer (MRO)
An MRO is a licensed physician who reviews all drug test results and serves as a gatekeeper between the laboratory and the employer. The MRO contacts drivers with non-negative results to identify any legitimate medical explanation (such as a valid prescription). The MRO then reports the final verified result — positive, negative, cancelled, or refusal — to the employer. Employers may not bypass the MRO or access lab results directly.
Federal marijuana policy and CDL drivers
Marijuana remains a Schedule I controlled substance under federal law. State laws permitting recreational or medical marijuana use do not apply to DOT-regulated testing. CDL drivers who test positive for THC metabolites face a Clearinghouse violation regardless of whether marijuana use was lawful in their state. A valid medical marijuana card is not a legitimate medical explanation under MRO review.
Frequently Asked Questions
Does Part 382 apply to intrastate-only CDL drivers?
Part 382 applies to drivers who operate in interstate commerce. Intrastate-only drivers may be subject to state drug and alcohol testing requirements, which vary by state. Carriers that operate both interstate and intrastate typically apply Part 382 to all drivers for consistency.
What happens if a driver refuses a DOT drug or alcohol test?
A refusal to test is treated the same as a positive result under Part 382. Refusals include failing to appear, leaving before the collection is complete, providing an insufficient specimen without a medical reason, tampering or adulterating a specimen, or refusing to cooperate. The refusal is reported to the Clearinghouse and triggers the return-to-duty process.
After a verified positive DOT drug test, what is the earliest a driver can return to safety-sensitive work?
There is no fixed minimum timeline. The driver must complete a SAP evaluation, follow the SAP's prescribed treatment or education, receive a follow-up SAP clearance, and pass a directly observed return-to-duty test. In practice this takes weeks to several months depending on the SAP's recommendation. Only after all steps are complete and the Clearinghouse status changes from "prohibited" to returned-to-duty may the driver operate again.
Can a CDL driver avoid a positive result by pointing to a state where marijuana is legal?
No. Marijuana remains a Schedule I controlled substance under federal law. State recreational or medical marijuana laws have no effect on DOT-regulated testing under 49 CFR Parts 382 and 40. An MRO will not accept a state-issued medical marijuana card as a legitimate medical explanation. A positive THC result is verified as a violation and reported to the Clearinghouse regardless of the driver's state of residence.